Pacira Pharmaceuticals Inc. (Nasdaq: PCRX) fell to a loss for the second quarter of 21 cents per share from break even in the year ago period but revenue climbed to top analyst estimates. The stock price leaped $7.14 to close at $44.63.
Revenue rises for Pacira Pharmaceuticals
August 04, 2016 at 18:58 PM EDT
